Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
Nabota 200ui
Nabota 200U — 200-unit pack of vacuum-dried Clostridium botulinum toxin type A from Daewoong. MFDS (KFDA) approved. Its active (prabotulinumtoxinA) is FDA-approved in the US under the separate brand Jeuveau (2019). The Korean Nabota brand itself is not FDA-approved. Note: vacuum-drying produces thin film — vial may appear empty. For licensed healthcare professionals only.
$48.90
Quantity discounts
| Quantity | Discount | Price |
|---|---|---|
| 5-9 | 3% | $47.43 |
| 10-19 | 5% | $46.46 |
| 20-Unlimited | 8% | $44.99 |
Nabota 200U — Vacuum-Dried Botulinum Toxin Type A (200-Unit)
What it is
Nabota 200U is Daewoong’s larger pack format of the Jeuveau-equivalent Korean botulinum — same vacuum-drying production, same 900 kDa biosimilar-to-Allergan-Botox profile as Nabota 100U, but with 200 units per vial. Designed for high-volume practices and multi-area protocols. MFDS (KFDA) approved in Korea. Its active ingredient (prabotulinumtoxinA) is FDA-approved in the US under the separate brand Jeuveau (2019). The Korean Nabota brand itself is not FDA-approved. Requires reconstitution with sterile preservative-free 0.9% saline before use.
What makes it distinctive
Nabota 200U combines vacuum-drying technology with 200U pack economics. Same manufacturing process as Nabota 100U delivers the same molecular integrity advantages at scale. Designed for high-throughput practices needing premium-tier Korean botulinum.
When the 200U Nabota pack delivers maximum value
Nabota 200U works well at approximately 2.5+ patients per single-vial session. Common 200U use scenarios: full upper face × 2 patients (≈ 100U each); combined cosmetic (glabellar 20U + crow’s feet 24U + masseter 100U = 144U) for single patient; bilateral hyperhidrosis (100U per axilla = 200U). The 24-hour reconstituted shelf life constraint applies — completing 200U worth of treatments within one day maximizes per-unit economics. The vacuum-drying advantage scales with the larger 200U pack.
Approved & off-label indications
Multi-area cosmetic combinations
Bilateral masseter hypertrophy (jaw slimming)
Multi-patient single-session use
Severe primary axillary hyperhidrosis bilateral (100U per axilla)
Full upper-face combinations (glabellar + forehead + crow’s feet + masseter)
High-volume practice premium tier
Body contouring (calf, deltoid hypertrophy)
EU/Canada/Saudi market distribution
Technical specifications
Detail for clinical, regulatory, and shipping reference.
| Active Ingredient | Clostridium botulinum toxin type A |
| Molecular Complex | 900 kDa (biosimilar to Allergan Botox) |
| Units per vial | 200 units |
| Form | Vacuum-dried powder (thin film at vial bottom) |
| Excipients | HSA + NaCl (200U scaling) |
| Manufacturer | Daewoong |
| Origin | South Korea |
| Approvals | MFDS (KFDA) approved · Manufactured in Korea |
| Onset / Duration | 2–4 days onset · peak day 7 · 3–5 months duration |
| Reconstitution | Sterile preservative-free 0.9% saline |
| Storage | 2–8 °C, protect from light, do not freeze |
| Reconstituted shelf life | 24 hours at 2–8 °C |
| Shelf life (unopened) | 36 months from manufacture |
| Intended use | Licensed medical professionals only |
Frequently Asked Questions
Why does the Nabota 200U vial look empty?
Same as Nabota 100U — Daewoong uses vacuum-drying production, leaving an ultra-thin film of active toxin at the vial bottom rather than a visible powder cake. The vial really does look empty — this is normal for vacuum-dried botulinum and not a packaging error or fake product. Hold the vial up to bright light at an angle to see the faint translucent film. The 200U pack has the same visual appearance as the 100U pack, just slightly larger vial size.
Is Nabota 200U the same formulation as Nabota 100U?
Yes — identical vacuum-drying production process, 900 kDa molecular complex, and HSA + NaCl excipients (scaled proportionally). Only the unit count per vial differs: 200 units versus 100. Its active (prabotulinumtoxinA) is FDA-approved in the US under the separate brand Jeuveau (2019).
How is Nabota 200U reconstituted?
200U is typically reconstituted with 5.0 mL preservative-free 0.9% saline for 4U/0.1 mL dilution (same concentration as 100U with 2.5 mL). Alternative: 200U with 2.5 mL yields 8U/0.1 mL for therapeutic large-muscle work. Use within 24 hours at 2–8 °C. Despite the empty-looking vacuum-dried vial, the standard saline volume yields standard concentration.
Does the FDA approval (Jeuveau) extend to the 200U pack in the US?
Its active (prabotulinumtoxinA) is FDA-approved in the US under the separate brand Jeuveau (2019). US-market Jeuveau is distributed via Evolus Inc. in standardized US packaging — buyers should verify they are purchasing Jeuveau (US version) rather than Nabota (Korean export version) for FDA-compliant US use. Outside the US, Nabota is the global brand name.
How do I verify Nabota 200U authenticity?
Same checks as Nabota 100U: (1) Daewoong branding on outer carton; (2) batch number matching between box and vial; (3) ‘200U’ clearly printed on labeling; (5) intact tamper-evident vial seal; (6) the empty-looking vial is normal — do not reject Nabota based on visual emptiness alone.
Related Products
Other botulinum toxin products from MJS Medicals — different manufacturers, formulations, and price points.
Browse all botulinum toxin products at MJS Medicals.
Safety
This product-specific: Nabota 200U uses vacuum-drying technology — the empty-looking vial is normal and does not indicate a fake product. Nabota 200U carries the same class-wide botulinum toxin warnings as all Type A products including potential distant toxin spread, neuromuscular junction disorder contraindications, and pregnancy/lactation contraindication. Always aspirate before injection; maintain emergency airway management equipment.
Botulinum toxin Type A is a prescription medical product for licensed healthcare professionals only. Contraindicated in neuromuscular junction disorders (myasthenia gravis, Lambert-Eaton, ALS); known hypersensitivity to botulinum toxin or excipients; pregnancy / breastfeeding; active local infection; concurrent aminoglycoside / anticholinesterase / curare-like drugs. Class-wide warning: rare distant toxin spread possible (symptoms hours-to-weeks post-injection). Maintain emergency airway management equipment and epinephrine.
Last reviewed: May 2026 · Source verification: Manufacturer official documentation · Multi-distributor cross-check
Related Products
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
1 review for Nabota 200ui
Clear filters